A 360-degree overview of paediatric NAFLD

Recent insights

Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition.

Original languageEnglish
Pages (from-to)1218-1229
Number of pages12
JournalJournal of Hepatology
Volume58
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Pediatrics
Obesity
Sedentary Lifestyle
Liver
Fatty Liver
Adipose Tissue
Fibrosis
Non-alcoholic Fatty Liver Disease
Therapeutics
Genes

Keywords

  • Children
  • Fibrosis
  • NAFLD
  • NASH

ASJC Scopus subject areas

  • Hepatology
  • Medicine(all)

Cite this

A 360-degree overview of paediatric NAFLD : Recent insights. / Nobili, Valerio; Svegliati-Baroni, Gianluca; Alisi, Anna; Miele, Luca; Valenti, Luca; Vajro, Pietro.

In: Journal of Hepatology, Vol. 58, No. 6, 06.2013, p. 1218-1229.

Research output: Contribution to journalArticle

Nobili, Valerio ; Svegliati-Baroni, Gianluca ; Alisi, Anna ; Miele, Luca ; Valenti, Luca ; Vajro, Pietro. / A 360-degree overview of paediatric NAFLD : Recent insights. In: Journal of Hepatology. 2013 ; Vol. 58, No. 6. pp. 1218-1229.
@article{feca1c212eaf43a29b23c832f32cc8dc,
title = "A 360-degree overview of paediatric NAFLD: Recent insights",
abstract = "Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition.",
keywords = "Children, Fibrosis, NAFLD, NASH",
author = "Valerio Nobili and Gianluca Svegliati-Baroni and Anna Alisi and Luca Miele and Luca Valenti and Pietro Vajro",
year = "2013",
month = "6",
doi = "10.1016/j.jhep.2012.12.003",
language = "English",
volume = "58",
pages = "1218--1229",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier B.V.",
number = "6",

}

TY - JOUR

T1 - A 360-degree overview of paediatric NAFLD

T2 - Recent insights

AU - Nobili, Valerio

AU - Svegliati-Baroni, Gianluca

AU - Alisi, Anna

AU - Miele, Luca

AU - Valenti, Luca

AU - Vajro, Pietro

PY - 2013/6

Y1 - 2013/6

N2 - Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition.

AB - Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition.

KW - Children

KW - Fibrosis

KW - NAFLD

KW - NASH

UR - http://www.scopus.com/inward/record.url?scp=84877920825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877920825&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2012.12.003

DO - 10.1016/j.jhep.2012.12.003

M3 - Article

VL - 58

SP - 1218

EP - 1229

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 6

ER -